Bid
--
-
Ask
- High-
- OPEN-
- VOL-
- MKT CAP-m
- LOW-
- CLOSE-
- AVG VOL-
- SHARES IN ISSUE734.05M
Company Profile
Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.
Classification
Market Indices | - |